Related references
Note: Only part of the references are listed.FSH dose is negatively correlated with number of oocytes retrieved: analysis of a data set with ∼650,000 ART cycles that previously identified an inverse relationship between FSH dose and live birth rate
Zaramasina L. Clark et al.
JOURNAL OF ASSISTED REPRODUCTION AND GENETICS (2021)
Step-Down of FSH- Dosage During Ovarian Stimulation - Basic Lessons to Be Learnt From a Randomized Controlled Trial
Barbara Lawrenz et al.
FRONTIERS IN ENDOCRINOLOGY (2021)
Do we need to measure progesterone in oocyte donation cycles? A retrospective analysis evaluating cumulative live birth rates and embryo quality
A. Racca et al.
HUMAN REPRODUCTION (2020)
Cumulative live birth rates according to the number of oocytes retrieved following the freeze-all strategy
Zhonghua Zhao et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2020)
Total follicle stimulating hormone dose is negatively correlated with live births in a donor/recipient model with fresh transfer: an analysis of 8,627 cycles from the Society for Assisted Reproductive Technology Registry
Kathryn L. Shaia et al.
FERTILITY AND STERILITY (2020)
Controlled ovarian hyperstimulation (COH) parameters associated with euploidy rates in donor oocytes
David H. McCulloh et al.
EUROPEAN JOURNAL OF MEDICAL GENETICS (2019)
Assessing the clinical significance of elevated progesterone during controlled ovarian stimulation: the unanswered question about embryo quality
V. S. Vanni et al.
HUMAN REPRODUCTION (2018)
Dosage of exogenous gonadotropins is not associated with blastocyst aneuploidy or live-birth rates in PGS cycles in Chinese women
Qianqian Wu et al.
HUMAN REPRODUCTION (2018)
High FSH dosing is associated with reduced live birth rate in fresh but not subsequent frozen embryo transfers
Erika M. Munch et al.
HUMAN REPRODUCTION (2017)
High gonadotropin dosage does not affect euploidy and pregnancy rates in IVF PGS cycles with single embryo transfer
Oleksii O. Barash et al.
HUMAN REPRODUCTION (2017)
Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials
P. Humaidan et al.
HUMAN REPRODUCTION (2016)
Impact of gonadotropin type on progesterone elevation during ovarian stimulation in GnRH antagonist cycles
B. Lawrenz et al.
HUMAN REPRODUCTION (2016)
Six years' experience in ovum donation using vitrified oocytes: report of cumulative outcomes, impact of storage time, and development of a predictive model for oocyte survival rate
Ana Cobo et al.
FERTILITY AND STERILITY (2015)
Gonadotropin dose is negatively correlated with live birth rate: analysis of more than 650,000 assisted reproductive technology cycles
Valerie L. Baker et al.
FERTILITY AND STERILITY (2015)
Individualization of controlled ovarian stimulation in IVF using ovarian reserve markers: from theory to practice
Antonio La Marca et al.
HUMAN REPRODUCTION UPDATE (2014)
Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI)
Irene Kwan et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2014)
Progesterone elevation does not compromise pregnancy rates in high responders: a pooled analysis of in vitro fertilization patients treated with recombinant follicle-stimulating hormone/gonadotropin-releasing hormone antagonist in six trials
Georg Griesinger et al.
FERTILITY AND STERILITY (2013)
Progesterone elevation and probability of pregnancy after IVF: a systematic review and meta-analysis of over 60 000 cycles
C. A. Venetis et al.
HUMAN REPRODUCTION UPDATE (2013)
Can cycle day 7 FSH concentration during controlled ovarian stimulation be used to guide FSH dosing for in vitro fertilization?
Yaakov Bentov et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2013)
LH-Receptor Gene Expression in Human Granulosa and Cumulus Cells from Antral and Preovulatory Follicles
Janni Vikkelso Jeppesen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles
Sesh Kamal Sunkara et al.
HUMAN REPRODUCTION (2011)
ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria
A. P. Ferraretti et al.
HUMAN REPRODUCTION (2011)
Clinical outcomes in relation to the daily dose of recombinant follicle-stimulating hormone for ovarian stimulation in in vitro fertilization in presumed normal responders younger than 39 years: a meta-analysis
M. D. Sterrenburg et al.
HUMAN REPRODUCTION UPDATE (2011)
Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles
E. Bosch et al.
HUMAN REPRODUCTION (2010)
Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF
Bart C. J. M. Fauser et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2010)
Cost-saving treatment strategies in in vitro fertilization: a combined economic evaluation of two large randomized clinical trials comparing highly purified human menopausal gonadotropin and recombinant follicle-stimulating hormone alpha
Jaroslaw Wechowski et al.
FERTILITY AND STERILITY (2009)
Can 200 IU of hCG replace recombinant FSH in the late follicular phase in a GnRH-antagonist cycle? A pilot study
C. Blockeel et al.
HUMAN REPRODUCTION (2009)
The science behind 25 years of ovarian stimulation for in vitro fertilization
NS Macklon et al.
ENDOCRINE REVIEWS (2006)
Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation
M Filicori et al.
FERTILITY AND STERILITY (2005)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
J Chang et al.
FERTILITY AND STERILITY (2004)
Modulation of folliculogenesis and steroidogenesis in women by graded menotrophin administration
M Filicori et al.
HUMAN REPRODUCTION (2002)
Share Paper
